Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Nitta Gelatin India Ltd (NITTAGELA) is currently trading at 1,659.95 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Nitta Gelatin India Limited is a leading manufacturer of ossein, gelatin, and collagen peptide. Its joint venture origins tie it to notable Japanese firms, enhancing its credibility. The company experienced significant capacity expansions over time, including its ossein and gelatin lines, showcasing its continuous growth ambition. Despite challenges like the mad cow disease, Nitta Gelatin has effectively adapted by diversifying its product range into areas like chitosan and collagen peptides. Innovative forays into the consumer market with products like GELIXER COLLAGENPEP highlight their attempt to connect directly with end-users. Strategic acquisitions and expansions, such as in the Aroor Industrial Estate and the merger of Reva Proteins, indicate a strong growth-driven strategy.
Over the past 52 weeks, Nitta Gelatin India Ltd has traded between a low of ₹765.05 and a high of ₹2,088.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Nitta Gelatin India Ltd has a market capitalization of approximately 1,502.83. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Nitta Gelatin India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 14.47 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,502.83 Cr, Nitta Gelatin India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Nitta Gelatin India Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Nitta Gelatin India Ltd is 14.47. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Consolidated net sales were Rs 161.73 crore and net profit was Rs 34.08 crore for the March 2026 quarter.
Nitta Gelatin India Limited is a leading manufacturer of ossein, gelatin, and collagen peptide. Its joint venture origins tie it to notable Japanese firms, enhancing its credibility.
The company experienced significant capacity expansions over time, including its ossein and gelatin lines, showcasing its continuous growth ambition.
Despite challenges like the mad cow disease, Nitta Gelatin has effectively adapted by diversifying its product range into areas like chitosan and collagen peptides.
Innovative forays into the consumer market with products like GELIXER COLLAGENPEP highlight their attempt to connect directly with end-users.
Strategic acquisitions and expansions, such as in the Aroor Industrial Estate and the merger of Reva Proteins, indicate a strong growth-driven strategy.
Chemicals & Petrochemicals
Specialty Chemicals
1,503 Cr
Low Risk
14.5
40.0
0.6
3.0
2,088.00
765.05
Sales CAGR
Profit CAGR
ROE
ROCE
Bearish
2
Neutral
7
Bullish
5
Bearish
14
Neutral
7
Bullish
25
Bearish
12
Neutral
0
Bullish
20
Bearish
2
Neutral
7
Bullish
5
Bearish
2
Neutral
7
Bullish
5
Bearish
12
Neutral
0
Bullish
20
Bearish
12
Neutral
0
Bullish
20
Bearish
12
Neutral
0
Bullish
20
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
524.95 | 1,820 Cr | 342.13 | 2.74 | 0.09 | 0.50 | 4.36 | 0.45 | ||
617.00 | 1,755 Cr | 790.55 | 37.43 | 0.00 | 2.90 | 5.84 | 1.53 | ||
339.95 | 1,743 Cr | 32.74 | 5.32 | 0.86 | 14.93 | 18.30 | 12.72 | ||
437.00 | 1,735 Cr | 56.42 | 9.56 | 0.12 | 16.46 | 20.87 | 14.38 | ||
1659.95 | 1,503 Cr | 14.47 | 3.00 | 0.42 | 19.02 | 25.82 | 17.62 | ||
993.50 | 1,244 Cr | 17.43 | 0.73 | 1.39 | 4.44 | 5.81 | 3.39 | ||
222.00 | 1,244 Cr | 25.24 | 2.81 | 0.00 | 11.73 | 15.16 | 8.97 | ||
| Median: 7 Co. | — | 524.95 | 1,735 Cr | 32.74 | 3.00 | 0.12 | 11.73 | 15.16 | 8.97 |
